scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12028-016-0271-9 |
P698 | PubMed publication ID | 27076286 |
P50 | author | Bradley J Molyneaux | Q57422778 |
P2093 | author name string | David O Okonkwo | |
Ryan M Rivosecchi | |||
Joseph Durkin | |||
P2860 | cites work | Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24632951 |
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association | Q28262545 | ||
Traumatic head injury in the anticoagulated elderly patient: a lethal combination. | Q34454622 | ||
Risk of thromboembolism following acute intracerebral hemorrhage | Q35018742 | ||
A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients | Q36146339 | ||
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. | Q38415781 | ||
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. | Q38446560 | ||
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. | Q38682353 | ||
Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage | Q44440532 | ||
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage | Q44865336 | ||
Degree of anticoagulation, but not warfarin use itself, predicts adverse outcomes after traumatic brain injury in elderly trauma patients | Q44954721 | ||
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage | Q45081496 | ||
Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality | Q46872824 | ||
Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis | Q48163528 | ||
Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage | Q48412367 | ||
Early hemorrhage growth in patients with intracerebral hemorrhage | Q48821770 | ||
Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage. | Q48876772 | ||
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. | Q49155525 | ||
Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrat | Q53539960 | ||
Intracerebral hematomas during anticoagulant treatment | Q68784254 | ||
Hematoma growth in oral anticoagulant related intracerebral hemorrhage | Q81785203 | ||
P433 | issue | 3 | |
P921 | main subject | (RS)-warfarin | Q407431 |
prothrombin complex concentrate | Q2044524 | ||
P304 | page(s) | 359-364 | |
P577 | publication date | 2016-12-01 | |
P1433 | published in | Neurocritical Care | Q15745303 |
P1476 | title | Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage | |
P478 | volume | 25 |
Q53281342 | Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review. |
Q48626887 | Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. |
Q55272081 | Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors. |
Q48282136 | Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage |
Search more.